Cart
0

Biobanking Market by Specimen Type (Blood products, Solid tissue, and Cell lines), Type of Biobank (Population Based Biobanks, and Disease-Oriented Biobanks), Ownership (National/Regional agencies, Non-profit organization, University, and Private), and Application (Therapeutic, and Research) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report
LI_182798
Pages: 205
Jun 2018 | 1664 Views
 
Author's : Prateeksha Kaul and Pallavi Jaiswal
Tables: 134
Charts: 15
 

Global Biobanking Market Overview:

Global biobanking market was valued at $47,062 million in 2017, and is estimated to reach $68,084 million by 2025, with a CAGR of 4.6% from 2018 to 2025. Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include rise in funding support by private & government organizations. Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict the market growth.

The global biobanking market is segmented by specimen type, type of biobank, ownership, application, and region. Based on specimen type, the market is categorized into blood products, solid tissue, cell lines, and others. On the basis of ownership, it is divided into national/regional agencies, nonprofit organization, university, and private. The applications covered in the study include therapeutic and research. Depending on type of biobank, the market is bifurcated into population and disease-oriented biobank. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

High incidence of chronic conditions

Several chronic diseases such as cancer, cardiovascular diseases, neurological disorders, and immunological disorders cannot be treated using conventional therapies, as they lead to harmful side effects. The risk of these side effects could be reduced by integrating it with stem cell therapy, which acts as a healing agent to reduce the damage caused by treatment doses. As per the statistics by the National Cancer Institute, around 14.5 million people are suffering from cancer in the U.S., and this number is expected to increase to 19 million in 2024. This is expected to increase the need of cord blood for therapeutic purposes, and thus fuel the global biobanking market growth.
 

Get more information on this report : Request Sample Pages

Increased funding support for biobanks

The samples from biobanks are used for various purposes such as research, therapeutics, clinical trials, and drug development. This has led to increase in funding by many non-profit and government organizations for the establishment of more public storage banks. For instance, more than 200 clinical trials are funded by the National Institutes of Health and are being carried out in the U.S. alone. In addition, in October 2017, National Institutes of Health granted $2.1 million to the UK ME/CFS Biobank, which represents a huge investment in biomedical research. Thus, rise in funds for biobanks is expected to fuel the biobanking market size.
 

by geography

Get more information on this report : Request Sample Pages

The key companies operating in the biobanking industry include ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions, Inc., LGC Limited, PrecisionMed, Inc., and ProMedDx LLC.

Key Benefits

  • The study provides an in-depth analysis of the global biobanking market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis from 2017to 2025 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Biobanking Market Key Segments:

By Specimen Type

  • Blood products
  • Solid tissue
  • Cell lines
  • Others

By Application

  • Therapeutic
  • Research

By Type of Biobank

  • Population-based biobanks
  • Disease-oriented biobanks

By Ownership

  • National/regional agencies
  • Nonprofit organization
  • University
  • Private

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in funds for biobanks
3.4.1.2. Increase in R&D activities for application of biobank specimens
3.4.1.3. Surge in prevalence of fatal chronic diseases

3.4.2. Restraints

3.4.2.1. Legal and ethical issues
3.4.2.2. Lack of awareness regarding biobanking

3.4.3. Opportunity

3.4.3.1. Untapped opportunities in the developing regions

3.4.4. Impact analyses

Chapter: 4: BIOBANKING MARKET, BY SPECIMEN TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Blood products

4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country

4.3. Solid tissues

4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country

4.4. Cell lines

4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country

4.5. Others

4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country

Chapter: 5: BIOBANKING MARKET, BY TYPE OF BIOBANK

5.1. Overview

5.1.1. Market size and forecast

5.2. Population-based biobanks

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Disease-oriented biobanks

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

Chapter: 6: BIOBANKING MARKET, BY OWNERSHIP

6.1. Overview

6.1.1. Market size and forecast

6.2. National/regional agencies

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Nonprofit organization

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. University

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Private organization

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter: 7: BIOBANKING MARKET, BY APPLICATION

7.1. Overview

7.1.1. Market size and forecast

7.2. Therapeutic

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Research

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

Chapter: 8: BIOBANKING MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends, growth factors, and opportunities
8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. biobanking market size and forecast

8.2.2.1.1. U.S. biobanking market size and forecast, by specimen type
8.2.2.1.2. U.S. biobanking market size and forecast, by type of biobank
8.2.2.1.3. U.S. biobanking market size and forecast, by ownership
8.2.2.1.4. U.S. biobanking market size and forecast, by application

8.2.2.2. Canada biobanking market size and forecast

8.2.2.2.1. Canada biobanking market size and forecast, by specimen type
8.2.2.2.2. Canada biobanking market size and forecast, by type of biobank
8.2.2.2.3. Canada biobanking market size and forecast, by ownership
8.2.2.2.4. Canada biobanking market size and forecast, by application

8.2.2.3. Mexico biobanking market size and forecast

8.2.2.3.1. Mexico biobanking market size and forecast, by specimen type
8.2.2.3.2. Mexico biobanking market size and forecast, by type of biobank
8.2.2.3.3. Mexico biobanking market size and forecast, by ownership
8.2.2.3.4. Mexico biobanking market size and forecast, by application

8.2.3. North America market size and forecast, by specimen type
8.2.4. North America market size and forecast, by type of biobank
8.2.5. North America biobanking market size and forecast, by ownership
8.2.6. North America biobanking market size and forecast, by application

8.3. Europe

8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany biobanking market size and forecast

8.3.2.1.1. Germany biobanking market size and forecast, by specimen type
8.3.2.1.2. Germany biobanking market size and forecast, by type of biobank
8.3.2.1.3. Germany biobanking market size and forecast, by ownership
8.3.2.1.4. Germany biobanking market size and forecast, by application

8.3.2.2. France biobanking market size and forecast

8.3.2.2.1. France biobanking market size and forecast, by specimen type
8.3.2.2.2. France biobanking market size and forecast, by type of biobank
8.3.2.2.3. France biobanking market size and forecast, by ownership
8.3.2.2.4. France biobanking market size and forecast, by application

8.3.2.3. UK biobanking market size and forecast

8.3.2.3.1. UK biobanking market size and forecast, by specimen type
8.3.2.3.2. UK biobanking market size and forecast, by type of biobank
8.3.2.3.3. UK biobanking market size and forecast, by ownership
8.3.2.3.4. UK biobanking market size and forecast, by application

8.3.2.4. Italy biobanking market size and forecast

8.3.2.4.1. Italy biobanking market size and forecast, by specimen type
8.3.2.4.2. Italy biobanking market size and forecast, by type of biobank
8.3.2.4.3. Italy biobanking market size and forecast, by ownership
8.3.2.4.4. Italy biobanking market size and forecast, by application

8.3.2.5. Spain biobanking market size and forecast

8.3.2.5.1. Spain biobanking market size and forecast, by specimen type
8.3.2.5.2. Spain biobanking market size and forecast, by type of biobank
8.3.2.5.3. Spain biobanking market size and forecast, by ownership
8.3.2.5.4. Spain biobanking market size and forecast, by application

8.3.2.6. Rest of Europe biobanking market size and forecast

8.3.2.6.1. Rest of Europe biobanking market size and forecast, by specimen type
8.3.2.6.2. Rest of Europe biobanking market size and forecast, by type of biobank
8.3.2.6.3. Rest of Europe biobanking market size and forecast, by ownership
8.3.2.6.4. Rest of Europe biobanking market size and forecast, by application

8.3.3. Europe market size and forecast, by specimen type
8.3.4. Europe market size and forecast, by type of biobank
8.3.5. Europe biobanking market size and forecast, by ownership
8.3.6. Europe biobanking market size and forecast, by application

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan biobanking market size and forecast

8.4.2.1.1. Japan biobanking market size and forecast, by specimen type
8.4.2.1.2. Japan biobanking market size and forecast, by type of biobank
8.4.2.1.3. Japan biobanking market size and forecast, by ownership
8.4.2.1.4. Japan biobanking market size and forecast, by application

8.4.2.2. China biobanking market size and forecast

8.4.2.2.1. China biobanking market size and forecast, by specimen type
8.4.2.2.2. China biobanking market size and forecast, by type of biobank
8.4.2.2.3. China biobanking market size and forecast, by ownership
8.4.2.2.4. China biobanking market size and forecast, by application

8.4.2.3. India biobanking market size and forecast

8.4.2.3.1. India biobanking market size and forecast, by specimen type
8.4.2.3.2. India biobanking market size and forecast, by type of biobank
8.4.2.3.3. India biobanking market size and forecast, by ownership
8.4.2.3.4. India biobanking market size and forecast, by application

8.4.2.4. Australia biobanking market size and forecast

8.4.2.4.1. Australia biobanking market size and forecast, by specimen type
8.4.2.4.2. Australia biobanking market size and forecast, by type of biobank
8.4.2.4.3. Australia biobanking market size and forecast, by ownership
8.4.2.4.4. Australia biobanking market size and forecast, by application

8.4.2.5. Rest of Asia-Pacific biobanking market size and forecast

8.4.2.5.1. Rest of Asia-Pacific biobanking market size and forecast, by specimen type
8.4.2.5.2. Rest of Asia-Pacific biobanking market size and forecast, by type of biobank
8.4.2.5.3. Rest of Asia-Pacific biobanking market size and forecast, by ownership
8.4.2.5.4. Rest of Asia-Pacific biobanking market size and forecast, by application

8.4.3. Asia-Pacific market size and forecast, by specimen type
8.4.4. Asia-Pacific market size and forecast, by type of biobank
8.4.5. Asia-Pacific biobanking market size and forecast, by ownership
8.4.6. Asia-Pacific biobanking market size and forecast, by application

8.5. LAMEA

8.5.1. Key market trends, growth factors, and opportunities
8.5.2. LAMEA market size and forecast, by country

8.5.2.1. Brazil biobanking market size and forecast

8.5.2.1.1. Brazil biobanking market size and forecast, by specimen type
8.5.2.1.2. Brazil biobanking market size and forecast, by type of biobank
8.5.2.1.3. Brazil biobanking market size and forecast, by ownership
8.5.2.1.4. Brazil biobanking market size and forecast, by application

8.5.2.2. South Africa biobanking market size and forecast

8.5.2.2.1. South Africa biobanking market size and forecast, by specimen type
8.5.2.2.2. South Africa biobanking market size and forecast, by type of biobank
8.5.2.2.3. South Africa biobanking market size and forecast, by ownership
8.5.2.2.4. South Africa biobanking market size and forecast, by application

8.5.2.3. Saudi Arabia biobanking market size and forecast

8.5.2.3.1. Saudi Arabia biobanking market size and forecast, by specimen type
8.5.2.3.2. Saudi Arabia biobanking market size and forecast, by type of biobank
8.5.2.3.3. Saudi Arabia biobanking market size and forecast, by ownership
8.5.2.3.4. Saudi Arabia biobanking market size and forecast, by application

8.5.2.4. Rest of LAMEA biobanking market size and forecast

8.5.2.4.1. Rest of LAMEA biobanking market size and forecast, by specimen type
8.5.2.4.2. Rest of LAMEA biobanking market size and forecast, by type of biobank
8.5.2.4.3. Rest of LAMEA biobanking market size and forecast, by ownership
8.5.2.4.4. Rest of LAMEA biobanking market size and forecast, by application

8.5.3. LAMEA market size and forecast, by specimen type
8.5.4. LAMEA market size and forecast, by type of biobank
8.5.5. LAMEA biobanking market size and forecast, by ownership
8.5.6. LAMEA biobanking market size and forecast, by application

Chapter: 9: COMPANY PROFILES

9.1. ASKION GmbH

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio

9.2. CTI BIOTECH

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio

9.3. Cureline, Inc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio

9.4. Excilone SARL

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio

9.5. Firalis S.A.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio

9.6. Hamilton Company

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio

9.7. LabVantage Solutions, Inc.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Product portfolio
9.7.4. Key strategic moves and developments

9.8. LGC Limited

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance

9.9. PrecisionMed, Inc.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio

9.10. ProMedDx, LLC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Product portfolio

LIST OF TABLES

TABLE 01. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 02. BLOOD PRODUCTS BIOBANKINGMARKET REVENUE FOR BLOOD PRODUCTS, BY REGION, 2017-2025 ($MILLION)
TABLE 03. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY REGION, 2017-2025 ($MILLION)
TABLE 04. BIOBANKING MARKET REVENUE FOR CELL LINES, BY REGION, 2017-2025 ($MILLION)
TABLE 05. BIOBANKING MARKET REVENUE FOR OTHER SAMPLES, BY REGION, 2017-2025 ($MILLION)
TABLE 06. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 07. POPULATION-BASED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 08. DISEASE-ORIENTED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 09. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 10. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY REGION, 2017-2025 ($MILLION)
TABLE 11. BIOBANKING MARKET REVENUE FOR NONPROFIT ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
TABLE 12. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY REGION, 2017-2025 ($MILLION)
TABLE 13. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
TABLE 14. BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 15. THERAPEUTIC BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 16. RESEARCH BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 17. BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 18. NORTH AMERICA BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 19. U.S. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 20. U.S. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 21. U.S. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 22. U.S. BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. CANADA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 24. CANADA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 25. CANADA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 26. CANADA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. MEXICO BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 28. MEXICO BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 29. MEXICO BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 30. MEXICO BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 32. NORTH AMERICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 33. NORTH AMERICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 34. NORTH AMERICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 35. EUROPE BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 36. GERMANY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 37. GERMANY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 38. GERMANY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 39. GERMANY BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 40. FRANCE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 41. FRANCE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 42. FRANCE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 43. FRANCE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 44. UK BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 45. UK BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 46. UK BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 47. UK BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. ITALY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 49. ITALY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 50. ITALY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 51. ITALY BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 52. SPAIN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 53. SPAIN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 54. SPAIN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 55. SPAIN BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 56. REST OF EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 57. REST OF EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 58. REST OF EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 59. REST OF EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 60. EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 61. EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 62. EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 63. EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 64. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 65. JAPAN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 66. JAPAN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 67. JAPAN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 68. JAPAN BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 69. CHINA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 70. CHINA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 71. CHINA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 72. CHINA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 73. INDIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 74. INDIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 75. INDIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 76. INDIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 77. AUSTRALIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 78. AUSTRALIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 79. AUSTRALIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 80. AUSTRALIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 85. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 86. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 87. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 88. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 89. LAMEA BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 90. BRAZIL BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 91. BRAZIL BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 92. BRAZIL BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 93. BRAZIL BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 94. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 95. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 96. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 97. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 98. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 99. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 100. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 101. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 102. REST OF LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 103. REST OF LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 104. REST OF LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 105. REST OF LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 106. LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 107. LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 108. LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 109. LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 110. ASKION: COMPANY SNAPSHOT
TABLE 111. ASKION: BUSINESS AREAS
TABLE 112. ASKION: PRODUCT PORTFOLIO
TABLE 113. CTI BIOTECH: COMPANY SNAPSHOT
TABLE 114. CTI BIOTECH: PRODUCT PORTFOLIO
TABLE 115. CURELINE: COMPANY SNAPSHOT
TABLE 116. CURELINE: PRODUCT PORTFOLIO
TABLE 117. EXCILONE: COMPANY SNAPSHOT
TABLE 118. EXCILONE: BUSINESS AREAS
TABLE 119. EXCILONE PRODUCT PORTFOLIO
TABLE 120. FIRALIS: COMPANY SNAPSHOT
TABLE 121. FIRALIS: OPERATING SEGMENTS
TABLE 122. FIRALIS: PRODUCT PORTFOLIO
TABLE 123. HAMILTON COMPANY: COMPANY SNAPSHOT
TABLE 124. HAMILTON COMPANY: PRODUCT SEGMENTS
TABLE 125. HAMILTON COMPANY: PRODUCT PORTFOLIO
TABLE 126. LABVANTAGE: COMPANY SNAPSHOT
TABLE 127. LABVANTAGE: PRODUCT PORTFOLIO
TABLE 128. LGC: COMPANY SNAPSHOT
TABLE 129. LGC: OPERATING SEGMENTS
TABLE 130. LGC: PRODUCT PORTFOLIO
TABLE 131. PRECISIONMED: COMPANY SNAPSHOT
TABLE 132. PRECISIONMED: SERVICE PORTFOLIO
TABLE 133. PROMEDDX: COMPANY SNAPSHOT
TABLE 134. PROMEDDX: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL BIOBANKING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. IMPACT ANALYSES, 2016
FIGURE 04. BIOBANKING MARKET REVENUE FOR BLOOD PRODUCTS, BY COUNTRY, 2017-2025 (%)
FIGURE 05. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY COUNTRY, 2017-2025 (%)
FIGURE 06. BIOBANKING MARKET REVENUE FOR CELL LINES, BY COUNTRY, 2017-2025 (%)
FIGURE 07. BIOBANKING MARKET REVENUE FOR OTHER SAMPLES, BY COUNTRY, 2017-2025 (%)
FIGURE 08. POPULATION-BASED BIOBANKS REVENUE, BY COUNTRY, 2017-2025 (%)
FIGURE 09. DISEASE-ORIENTED BIOBANKS REVENUE, BY COUNTRY, 2017-2025 (%)
FIGURE 10. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY COUNTRY, 2017-2025 (%)
FIGURE 11. BIOBANKING MARKET REVENUE FOR NONPROFIT ORGANIZATION, BY COUNTRY, 2017-2025 (%)
FIGURE 12. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY COUNTRY, 2017-2025 (%)
FIGURE 13. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY COUNTRY, 2017-2025 (%)
FIGURE 14. THERAPEUTIC BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 (%)
FIGURE 15. RESEARCH BIOBANKING MARKET REVENUE, BY COUNTRY, 2017–

 

Globally, chronic diseases, such as cancer, constitute a major proportion of health and economic burden; hence, the need of development of effective treatment options is the major necessity of the hour.

The market of biobanking gained prominence in the recent years, and is expected to witness a significant rise in the near future. This is attributed to rise in incidence of fatal diseases, increase in funding by government for biobank research projects, and surge in awareness towards the benefits of biobank specimens such as cord blood for the human health. However, certain limitations such as ethical and legal issues related to biobanking are expected to restrain the market growth.

Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players during the forecast period. However, Europe is expected to maintain its dominance in the global market during the forecast period

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Biobanking Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo